| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10966829 | Vaccine | 2012 | 5 Pages |
Abstract
⺠We describe HPV vaccine status in women with precancerous cervical lesions. ⺠We examine HPV vaccine impact on HPV 16/18-related precancerous cervical lesions. ⺠20% of women aged 18-31 years initiated HPV vaccination on/after abnormal Pap. ⺠Among women vaccinated >24 months before the abnormal Pap, there was a smaller percentage of lesions due to HPV 16/18.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Suzanne E. Powell, Susan Hariri, Martin Steinau, Heidi M. Bauer, Nancy M. Bennett, Karen C. Bloch, Linda M. Niccolai, Sean Schafer, Elizabeth R. Unger, Lauri E. Markowitz,